entertainment -WSS

entertainment

author：comprehensive 2025-09-03 05:31:16 - browse：9673

The Food and Drug Administration’s advisory panel of pediatric experts met on Tuesday to discuss advances in artificial womb technology, which aim to save the lives of premature babies.

The goal of the meeting was to discuss measures for evaluating the safety and efficacy of an artificial womb. The group grappled with the limits of current animal data, as well as the ethical difficulties in running human trials. On Wednesday, the committee’s meeting will be closed to the public in order to protect trade secrets.

Extremely premature babies, defined as infants born at less than 28 weeks, rarely survive. About half of infants born at 23 weeks survive, according to a 2022 study in the Journal of the American Medical Association, and at 22 weeks just 10% survive. This population represents less than 2% of all premature babies, but the problem is growing; the Centers for Disease Control and Prevention reported that the preterm birth rate rose by 4% between 2020 and 2021.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： The Karikó problem: Lessons for funding basic research

explore

WSS

A virus, fished out of a lake, may have saved a man’s life

Sana to lay off nearly a third of staff, de

Nobel honors Karikó and Weissman's enduring partnership

Histogen: Failed biotech offers rare public look inside

New oral drug delivery patch is modeled after octopus tentacles

European officials brace for rough respiratory virus season

Wikipedia

entertainment

entertainment

Anesthesiologist group: stop taking Ozempic before surgery

The Karikó problem: Lessons for funding basic research

Medicare details structure of new drug price negotiation program

RSV injection headlines need to be accurate for good uptake

Dobbs anniversary: the lost opportunity of abortion as health care

The biotech scorecard for Q4: 16 stock

Bright Health sells Medicare Advantage business to Molina

Will an HIV vaccine ever be a reality?

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Was Amgen transparent enough on FDA's concern on cancer drug?

entertainment

Chan Zuckerberg Biohub Chicago to focus on inflammation

The United States is paying nearly triple for new Covid vaccines

RSV injection headlines need to be accurate for good uptake

Some top drug companies are starting to take action on climate

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

Medicare innovation center doesn’t save money, experts say

hotspot

hotspot

explore

knowledge